Lugol‐unstained lesions location in the esophagus affects the detection rate of malignancy: a population‐based study

Abstract

IntroductionThis study aimed to evaluate the impact of Lugol‐unstained lesion (LUL) location on the detection yield, which may help the endoscopist select targets for biopsy.MethodsWe enrolled 1064 subjects who had LULs at the baseline screening of a population‐based randomized controlled trial. There were 1166 LULs with recorded location and pathologic diagnosis, and these were used for analysis. The detection rate of severe dysplasia and above (SDA) was calculated as the number of LULs identified as SDA divided by the number of LULs biopsied. Logistic regression with a generalized estimating equation was applied to evaluate the association between the location of a given LUL and the risk of the LUL being SDA.ResultsThe detection rate of SDA for LULs located in the lower, middle, and upper esophagus increased from 5.9% and 10.9% to 16.7%. LUL location was significantly associated with having SDA (adjusted odds ratio (OR)upper vs. lower = 2.88, 95% confidential interval (CI) = 1.48–5.60; adjusted ORmiddle vs. lower = 1.63, 95% CI = 0.96–2.76), and the association was stronger in subgroups with a family history of esophageal squamous cell carcinoma (ESCC) (adjusted ORupper vs. lower = 9.72, 95% CI = 2.57–36.69; adjusted ORmiddle vs. lower = 3.76, 95% CI = 0.93–15.21).ConclusionsOur results suggest that more attention should be paid by endoscopists to LULs in the upper and middle esophagus, particularly for individuals with a family history of ESCC.

Effectiveness of Endoscopic Screening on Esophageal Cancer Incidence and Mortality: A 9-Year Report of the Endoscopic Screening for Esophageal Cancer in China (ESECC) Randomized Trial

“…33 However, our previous studies have shown that nondysplastic Lugol-unstained lesions (ND-LULs) could be the initial stage of ESCC, and endoscopic features of LULs independently indicate the risk of progression of precursor lesions. [34][35][36][37][38] Although we have taken these factors into account in the surveillance of the ESECC trial, the above commonly adopted pathology-based criteria would still have resulted in insufficient surveillance of ND-LULs to some extent, and therefore dilute the screening effect in this trial.…”